Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

Completed · Phase 2

Conditions studied: Carcinoma, Non-Small-Cell Lung

In brief

The purpose of this study is to test whether SU011248 has activity and is safe in patients with metastatic non-small cell lung cancer (NSCLC) who have failed a platinum-containing regimen and docetaxel.

Key facts

Study ID

NCT00092001

Run by

Pfizer

People needed

111

Starts

2005-01-01

Expected to finish

2007-03-01

Last updated by the study team

2008-10-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed advanced or metastatic Non-Small Cell Lung Cancer that cannot be cured with surgery, radiation, or combination thereof
• No more than 2 prior chemotherapy treatments including treatment with a platinum containing therapy
• Evidence of measurable disease by radiographic technique
• Male or Female, 18 years or older
• ECOG performance status of 0 or 1
• Resolution of all acute toxicities of prior therapies
• Adequate organ function

You may not qualify if…

• Major surgery or radiation therapy within 4 weeks
• Severe hemorrhage within 4 weeks
• Previous treatment with anti-angiogenesis agents
• Diagnosis of second malignancy within last five 5 years
• History of or known brain metastases, spinal cord compression, or carcinomatous meningitis
• Known HIV
• Serious acute or chronic illness
• Current treatment on another clinical trial
• Pregnant or breastfeeding

Where it is running

• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — City of Saint Peters, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — Chapel Hill, North Carolina, United States
• Pfizer Investigational Site — Clinton, North Carolina, United States
• Pfizer Investigational Site — Goldsboro, North Carolina, United States
• Pfizer Investigational Site — Pollocksville, North Carolina, United States
• Pfizer Investigational Site — Wilson, North Carolina, United States
• Pfizer Investigational Site — Pittsburgh, Pennsylvania, United States
• Pfizer Investigational Site — Charlottesville, Virginia, United States
• Pfizer Investigational Site — Orbassano (Torino), Italy
• Pfizer Investigational Site — Badalona, Barcelona, Spain
• Pfizer Investigational Site — Barcelona, BARCELONA, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.